Andrew McIver

Person

Durham, NC, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pyrrolopyrimidine nucleosides and analogs thereof
- Patent number 11,981,700
- Issue date May 14, 2024
- Chimerix, Inc.
- John Henry Bougher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolopyrimidine nucleosides and analogs thereof
- Patent number 10,941,175
- Issue date Mar 9, 2021
- Chimerix, Inc.
- John Henry Bougher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thiazole derivatives useful as mutant IDH1 inhibitors for treating...
- Patent number 10,836,759
- Issue date Nov 17, 2020
- The University of North Carolina at Chapel Hill
- Matthew Brian Boxer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutant IDH1 inhibitors useful for treating cancer
- Patent number 10,703,746
- Issue date Jul 7, 2020
- The United States of America, as represented by the Secretary, Department of...
- Matthew Brian Boxer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolopyrimidine nucleosides and analogs thereof
- Patent number 10,407,457
- Issue date Sep 10, 2019
- Chimerix, Inc.
- John Henry Bougher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidine compounds for the treatment of cancer
- Patent number 9,771,330
- Issue date Sep 26, 2017
- The University of North Carolina at Chapel Hill
- Xiaodong Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrimidine nucleosides and analogs thereof
- Patent number 9,708,359
- Issue date Jul 18, 2017
- Chimerix, Inc.
- John Henry Bougher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrimidine nucleosides and analogs thereof
- Patent number 9,701,706
- Issue date Jul 11, 2017
- Chimerix, Inc.
- John Henry Bougher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidine compounds for the treatment of cancer
- Patent number 9,567,326
- Issue date Feb 14, 2017
- The University of North Carolina at Chapel Hill
- Xiaodong Wang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF
- Publication number 20220002335
- Publication date Jan 6, 2022
- CHIMERIX, INC.
- John Henry Bougher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF
- Publication number 20200199167
- Publication date Jun 25, 2020
- CHIMERIX, INC.
- John Henry Bougher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THIAZOLE DERIVATIVES USEFUL AS MUTANT IDH1 INHIBITORS FOR TREATING...
- Publication number 20190241551
- Publication date Aug 8, 2019
- Matthew Brian BOXER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUTANT IDH1 INHIBITORS USEFUL FOR TREATING CANCER
- Publication number 20190071434
- Publication date Mar 7, 2019
- The USA, as represented by the Secretary, Department of Health and Human Serv...
- Matthew Brian Boxer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF
- Publication number 20170253628
- Publication date Sep 7, 2017
- CHIMERIX, INC.
- John Henry Bougher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Andrew McIver

Person

Patents Grantslast 30 patents

Pyrrolopyrimidine nucleosides and analogs thereof

Pyrrolopyrimidine nucleosides and analogs thereof

Thiazole derivatives useful as mutant IDH1 inhibitors for treating...

Mutant IDH1 inhibitors useful for treating cancer

Pyrrolopyrimidine nucleosides and analogs thereof

Pyrimidine compounds for the treatment of cancer

Pyrrolopyrimidine nucleosides and analogs thereof

Pyrrolopyrimidine nucleosides and analogs thereof

Pyrimidine compounds for the treatment of cancer

Patents Applicationslast 30 patents

PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF

PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF

THIAZOLE DERIVATIVES USEFUL AS MUTANT IDH1 INHIBITORS FOR TREATING...

MUTANT IDH1 INHIBITORS USEFUL FOR TREATING CANCER

PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF